Scarica l'app Stockscreener
7.86
0.63%
-0.06
Dopo l'orario di chiusura:
7.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™ - PR Newswire UK
Press Release Distribution & PR Platform - ACCESS Newswire
Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year - Yahoo
I-Apollo Hospitals, yethula i-“Cancer Champions United” isinyathelo esiyingqayizivele sokunikeza amandla Abasinde Ngomdlavuza! - Apollo Hospitals
Patient Derived Xenograft Model Market Future Business - openPR.com
Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 - ACCESS Newswire
Investors Give Champions Oncology, Inc. (NASDAQ:CSBR) Shares A 28% Hiding - simplywall.st
Apollo Hospitals, yakhazikitsa "Cancer Champions United" njira yapadera yopatsa mphamvu Opulumuka Khansa! - Apollo Hospitals
How To Trade (CSBR) - news.stocktradersdaily.com
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView
Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) - Yahoo Finance
Champions Oncology target raised to $12 at Craig-Hallum By Investing.com - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript - MSN
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology Achieves Record Revenue and Profit - TipRanks
Champions Oncology earnings beat by $0.37, revenue topped estimates - Investing.com Canada
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations - Investing.com
CHAMPIONS ONCOLOGY Earnings Results: $CSBR Reports Quarterly Earnings - Nasdaq
Champions Oncology stock surges as earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology stock surges as earnings beat expectations - Investing.com India
Champions Oncology Reports Record Quarterly Revenue and Net Income - TradingView
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million - ACCESS Newswire
Stock Index Futures Gain After Yesterday’s Selloff, U.S. JOLTs Report in Focus - TradingView
Earnings Scheduled For March 11, 2025 - Benzinga
CHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Champions Oncology Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 - ACCESS Newswire
When Will Champions Oncology Report Q3 Results? Key Date for Oncology Research Leader - StockTitan
(CSBR) Technical Pivots with Risk Controls - Stock Traders Daily
mPATH Health Triumphs with Double Recognition for Excellence in Cancer Care - PR Newswire
Targeted Oncology Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program - Florida Trend
CSBR stock hits 52-week high at $10.91 amid robust growth - MSN
We're Interested To See How Champions Oncology (NASDAQ:CSBR) Uses Its Cash Hoard To Grow - Yahoo Finance
Galleri Classic: Fred Couples, Ernie Els, Vijay Singh commit to play - firstcallgolf.com
Champions Oncology Reports Quarterly Revenue of $6.7 Million - ACCESS Newswire
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 - ACCESS Newswire
ZERO Advocacy Summit Ignites National Movement for Prostate Cancer Reform, Rallying Patients, Survivors, and Policymakers on Capitol Hill - Yahoo Finance
Champions Oncology Reports Record Quarterly Revenue of $9.5 Million - ACCESS Newswire
Champions Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $7.6 Million - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million - ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) pulls back 16% this week, but still delivers shareholders notable 57% return over 1 year - Simply Wall St
CSBRChampions Oncolo Latest Stock News & Market Updates - StockTitan
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $10.8 Million - ACCESS Newswire
Prospect High students champions in fight against blood cancer - Daily Herald
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 - ACCESS Newswire
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting - ACCESS Newswire
Revolutionary Cancer Research Alert: Champions Oncology Unveils 17 Game-Changing Studies at AACR 2025 - StockTitan
CancerX Launches 2025 Accelerator to Drive Innovation in Oncology - Business Wire
Flow Cytometry Market Size to Worth USD 12.11 Billion by 2034 - GlobeNewswire
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 - ACCESS Newswire
(CSBR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $13.1 Million - ACCESS Newswire
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):